Brean Capital believes the bear case for Rovi (ROVI) is being overstated and reiterates a Buy rating on the stock in a research note titled "To Catch a Falling Knife." Brean analysts Todd Mitchell and Giancarlo Chaux admit that Rovi is "poorly positioned" in its intellectual property claims against Netflix (NFLX). The analysts, however, think Rovi will be able to renew its licensing deals with large U.S. service providers in 2016 regardless of the outcome of the Netflix case. They also do not think a loss in the case is inevitable. Mitchell and Chaux keep a Buy rating on Rovi with a $31 price target.

Comcast (CMCSA) is scheduled to announce quarterly results on April 25, while Paramount (PARA) and Warner Bros. Discovery (WBD) are... To see the rest of the story go to thefly.com. See Story Here